Tyler Luu

Tyler Luu is a Clinical Researcher at Yale School of Medicine (Yale SOM), focusing on antibiotic stewardship, hospital epidemiology, and infectious diseases. He earned his BS in Molecular Biology from UCLA (2015) and MD from University of California, Riverside (exact year not specified). He completed an Internal Medicine residency at Loyola University Chicago in 2023 and is board-certified in Internal Medicine (ABIM, 2023).

His research spans antibiotic de-escalation strategies, post-transplant malignancy risks, and rare infectious disease cases. He has published in peer-reviewed journals such as Am J Med, Cureus, and Frontiers in Oncology. Notable contributions include analyzing immunosuppressive medication risks in transplant patients (2023) and investigating multidrug-resistant infections like Historplasma co-infections (2025).

• Education:
  • BS, Molecular Biology, UCLA, 2015
  • MD, University of California, Riverside
  • Internal Medicine Residency, Loyola University Chicago, 2023

Luu has received awards including the Resident Research Abstract Winner (2022) and scholarships focused on diversity in medicine. He actively reviews manuscripts for Am J Med, Cureus, and Tropical Medicine and Infectious Disease.